Professor Gillian Mead is Chair of Stroke and Elderly Care Medicine. In her research she aims to find out how to improve recovery and quality of life in people who survive a stroke.
Stroke is the major cause of severe adult disability. My research aims to find out how to improve recovery and quality of life of people who survive a stroke. I am trialling several treatments (including exercise and antidepressants) to find out whether they might improve quality of life and recovery from a stroke.
My research is driven by the clinical needs of patients. I employ a variety of research designs, including systematic reviews, observational studies, qualitative research methodology and randomised controlled clinical trials.
My research is focused on the under-researched area of ‘Life after Stroke’. I lead programmes of research in fatigue, exercise and cognition after stroke; these topics are amongst the top 10 priorities for stroke research. I am co-principal investigator of the FOCUS Trial (Fluoxetine or control Under Supervision), a UK multicentre trial that seeks to determine whether fluoxetine improves recovery after stroke.
I am also interested in the role of exercise for health in other groups of people including healthy older people, people with depression and people with schizophrenia.
I am co-investigator on the MRC-funded Seniors’ Understanding Sedentary Patterns project (led by Professor Dawn Skelton) and the EPSRC-funded Mobility Mood and Place project (lead Professor Catharine Ward Thompson).
I am a member of the Cochrane Stroke Group and Cognitive Improvement and Dementia editorial board groups, an associate member of the Centre for Cognitive Ageing and Cognitive Epidemiology (CCACE) and a member of the Geriatric Medicine Unit.